The World Health Organization (WHO) on December 31, 2019, was informed of several cases of respiratory diseases of unknown origin in the city of Wuhan (News 2020, https://www.ncbi.nlm.nih.gov/nuccore/MN908947) in the Chinese Province of Hubei, the clinical manifestations of which were similar to those of viral pneumonia and manifested as fever, cough, and shortness of breath (http://wjw.wuhan.gov.cn/front/web/showDetail/2020011109036). As of January 30, 2020, the WHO classified this epidemic as a global health emergency (Chung et al. 2020). The disease caused by the virus is named the new coronavirus disease 2019 and it will be abbreviated as 2019-nCoV and COVID-19 (https://twitter.com/WHOWPRO/status/1219478541865144320).
In Latin, corona means crown. On their surface, coronaviruses have spiky projections that resemble crowns. Viruses with crowns are therefore called coronaviruses. It is a large family of viruses in bats, birds, cats, cattle, and camels. In most cases, common cold is the symptom of human coronavirus. Four types of human coronaviruses are responsible for 10 to 30 percent of the reliable sources of upper respiratory infections in adults (Song et al. 2020; Rapid Risk Assessment 2020).
Coronaviruses with crown
A new type of coronavirus can occur when an animal coronavirus can transmit the disease to humans when germs are transferred from an animal to a human. This can cause serious diseases. This can be due to a variety of factors, particularly the lack of human immunity to the new virus.
The coronavirus (CoV) with crowns first identified in 2003 causes the users-severe acute respiratory syndrome, is abbreviated as SARS-CoV. The coronavirus with crowns first identified in 2012 causes disease, called as the Middle East Respiratory Syndrome is abbreviated as MERS-CoV (2019). The new coronavirus with crowns first identified in China in 2019 is abbreviated as 2019-nCoV and COVID-19. And, COVID-19 is also termed as SARS-CoV-2. Photographs of these three viruses with crowns are shown in Fig. 1.
Signs and symptoms of COVID-19 in human
The symptoms of COVID-19 in common are fever, dry cough, and fatigue. Symptoms in some of the infected patients may experience a runny nose, pain, nasal congestion, diarrhea, or sore throat. And, these symptoms are generally mild and start gradually. Some people are infected but do not develop symptoms and do not feel well. About 80% of people recover from the disease without special treatment. Approximately one in five people infected with COVID-19 is seriously ill and has difficulty breathing. Seniors and people with underlying conditions such as heart problems, diabetes, or high blood pressure are in our society, more likely to indirectly develop serious conditions. Based on the latest data, around 3-4 % of the reported cases worldwide have died, but the mortality rate varies depending on the location, age, and presence of underlying diseases.
The new coronavirus in China
The Chinese Municipal Health Commission if Wuhan which is in Wuhan City, Hubei Province, reported on December 31, 2019, a group of 27 unknown etiology pneumonia cases, including seven serious cases, related to the Huanan seafood wholesaler in Wuhan, a market for live animals selling various animal species. Clinical features in these cases similar to infectious respiratory diseases such as dyspnea, fever, and bilateral lung infiltrate on the chest X-ray (radiographs). The authorities put all cases in solitary confinement, launched contact tracking activities, and launched environmental hygiene and hygiene measures at the market that were closed to the public usage on January 1, 2020. The Chinese authorities at that time had reported no transmission within human and no healthcare professional cases.
On January 9, 2020, the Chinese CDC reported that a new coronavirus (2019-nCoV) was discovered to be responsible for 15 of the 59 cases of pneumonia (http://www.nhc.gov.cn/yjb/s3578/202001/930c021cdd1f46dc832fc27e0cc465c8.shtml). On January 10, 2020, the first new sequence in the coronavirus genome was made available to the public (http://wsjkw.gd.gov.cn/zwyw.yqxx/content/post.2876926.html). The footage was uploaded to the database GenBank (Rapid Risk Assessment 2020) and downloaded as part of the Global Influenza Data Sharing Initiative (GISAID). A preliminary analysis has shown that the new coronavirus clusters (2019-nCoV) differ from the basic genome of known bat CoVs. December 31, 2019, to January 20, 2020, the confirmed cases 295 are reported in the laboratory, including four deaths (http://virological.org/t/initialgenome-release-of-novel-coronavirus/319) (Table 1).
Table 1 Outcomes of COVID-19 infection Reporting Country on 20 January 2020 (Chen et al. 2020) Among the cases reported in Wuhan were 15 health professionals (Algahtani et al. 2016). Of the 295 cases confirmed in the laboratory, China reported 291 cases ( 270 cases were reported in Wuhan City, 14 cases in Guangdong, 5 cases in Beijing, and 2 in Shanghai ) (http://www.nhc.gov.cn/yjb/s3578/202001/930c021cdd1f46dc832fc27e0cc465c8.shtml). The city of Wuhan reports that 169 cases are still in the hospital, of which 35 are critically ill and nine are critically ill (http://wjw.wuhan.gov.cn/front/web/showDetail/2020012109083). The ECDC does not know whether the cases were brought to solitary confinement solely for medical purposes or less severe cases.
In Guangdong, 2 of the 14 reported cases had not traveled to Wuhan, China, but have had contact with confirmed cases in the past (http://wsjkw.gd.gov.cn/zwyw.yqxx/content/post.2876926.html). The other four cases confirmed in the laboratory relate to travel ( 1 in South Korea, 1 in Japan, and 2 in Thailand ) (Rapid Risk Assessment 2020) (http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989, http://xinhuanet.com/english/2020-01/20/c138721535:htm).
Of the 4 reported deaths in China, the first happened in a 61-year-old patient on January 9, 2020, with underlying medical conditions who visited the wholesale market, Huanan seafood in Wuhan (http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989). A second death on January 15, 2020, occurred in a 69-year-old man with multiple organ failure (http://wjw.wuhan.gov.cn/front/web/showDetail/2020011609057). The third death was reported on January 15, 18, 2020 (http://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077), the fourth death occurred on January 19, 2020, in an 89-year-old woman due to coronavirus with pre-existing diseases (http://wjw.wuhan.gov.cn/front/web/showDetail/2020012109083).
Symptoms of cases confirmed including travel-related cases in the laboratory occur from December 8, 2019, to January 18, 2020. More than half of the confirmed cases were men. In the cases reported, the range of age is between 10 and 89 years (http://wsjkw.gd.gov.cn/zwyw.yqxx/content/post.2876926.html). The history of exposure to Huanan seafood wholesalers in Wuhan or other living markets in China is not yet known for the majority of the reported cases recently (http://xinhuanet.com/english/2020-01/20/c138721535:htm). In China, 1,739 patients were identified as close contacts, and on continuous follow-up, 817 patients completed the observation period, while 922 patients remain under medical observation (http://wjw.wuhan.gov.cn/front/web/showDetail/2020011609057, http://wjw.wuhan.gov.cn/front/web/showDetail/2020011509046).
On December 31, 2019, the WHO has been made aware of several cases of respiratory diseases of unknown origin from Wuhan City of China, with similar clinical presentations of viral pneumonia and manifested by cough, fever, and short breath. As of January 30, 2020, the WHO classified this epidemic as a global health emergency (http://wjw.wuhan.gov.cn/front/web/showDetail/2020012109083).
Literature survey of SARS-CoV
Peiris et al. (2004) review the scientific advances made in the study of the virus, SARS-CoV. They also highlight the advances made in the development of therapies and vaccines. They designed a method for the detection and control of future infectious disease threats. Stadler et al. (2003) presents a review on SARS. And they present that the 114-day SARS epidemic has hit 29 countries, affected 8,098 people, killed 774 people, and nearly paralyzed the economy of Asia. Aggressive quarantine measures possibly supported by rising temperatures during summer and successfully ended and ensured the first outbreak of SARS. They are investigating the genomics of the SARS-CoV, its phylogeny, its antigen structure, its immune response, and its possible therapeutic interventions when the SARS epidemic recurs (Boulos1 and Geraghty 2020) (https://www.bcm.edu/departments/molecular-virology-and-microbiology/emerging-infectionsandbiodefense/sars-virus).
Literature survey of MERS-CoV
Algahtani et al. (2016) present a review on MERS-CoV. In this review, a report of two cases and the literature review are given. In September 2012, the coronavirus of the respiratory syndrome in the Middle East (MERS-CoV) was first discovered in Saudi Arabia. It has caused in the laboratory test more than 1,600 confirmed and more than 580 deaths. MERS-CoV infection is a serious illness that affects many lung, kidney, hematological, and gastrointestinal complications. In Algahtani et al. (2016), in two adult patients, the neurological complaint due to MERS-CoV is reported and they make the pathological hypothesis.
Literature survey of COVID-19
Several pneumonia patients of unknown cause were discovered in the month of December 2019 in a Chinese city of Wuhan. On January 7, 2020, the pathogen was identified as a new CoV, which will later be referred to as the new coronavirus 2019 (2019-Nov). Genome sequencing has shown that the COVID-19 genetic sequence is similar to that of the CoV associated with SARS, and a precise medical approach to treating this disease is imperative to detect the spread of the virus and control it. In this article, Wang et al. (2020) present such an approach to treating pneumonia associated with 2019, which is based on the unique properties of the recently discovered virus and our experience with CoVs of China at the West China Hospital in Chengdu.
Adhikari et al. (2020) make a review of COVID-19 at the early period. The background of this review is from December 2019, COVID-19 is the cause of an epidemic of respiratory diseases in Wuhan, China. This epidemic has spread to 19 countries and as of January 31, 2020, with 1,791 infected cases, including 213 deaths. WHO declared it an emergency of public concern for public health.
Tavakoli et al. (2020) said at the start of the new year 2020, China alarmed the WHO to a group of unusual cases of pneumonia in Wuhan. After much speculation, a new kind of Coronavirus was introduced as a pathogen COVID-19 and a virus known to cause in human SARS-CoV-2. The fast spread of COVID-19 has caused fear worldwide. The new outbreak of the coronavirus declared an international health emergency of international importance on January 30, 2020. The incubation period is within 2 to 10 days, according to the WHO. The death rate in SARC-CoV-2 infected patients is 4.3 % and the results show that mortality is higher in elders and patients with chronic diseases, including coronary artery disease of diseased patients, high blood pressure, chronic lung disease, and diabetes. The rate of mortality in healthy is less than 1 %.
Rabi et al. (2020) present a summary of current knowledge about the new coronavirus and the disease it causes. Alene and Yadeta in Alene and Yadeta (2020) present a review article to understand the cause, to identify methods, to investigate or control coronavirus caused COVID-19 infection, and to avoid future events. Razvan Azamfirei in Alene and Yadeta (2020) present a review on coronavirus caused COVID-19, since the identification of the new coronavirus 2019 (2019-nCoV) in December 2019, an overwhelming feeling of panic has caught the public discourse. This should be reinforced by the recent WHO declaring the new coronavirus outbreak an internationally worrying public health emergency. It is the third major occurrence of a zoonotic coronavirus transmission that crosses the species barrier to infect humans and is unlikely to be the last.
In the recent past, we have successfully managed SARS, MERS, Zika, and Ebola. Our scientific community is ready and alert, as shown by the incredibly quick response to the present outbreak. It is not the last time we hear about the coronavirus. They have significant infection potential and more scientific resources should be provided to help understand and reduce the severity of future epidemics. Despite the high infectivity, the rate of mortality maintains low value; WHO and State governments are simultaneously taking the necessary preventive measures to reduce the spread of the infection.
Chung et al. (2020) contacted 21 patients with a history of contact with people from the endemic center of Wuhan, China, and analyzed and presented their findings. Chung et al. (2020) hypothesize that the lungs may respond and heal similarly as of SARS and MERS, although it is too early to have imaging descriptions of 2019-to in the more subacute, chronic, or treated patient population. Rabi et al. (2020) contacted about 50 of 51 patients with a history of contact with people from the endemic center of Wuhan, China, and analyzed and presented their findings.
Singapore has well-developed protocols for COVID-19 outbreak preparation. Cleland et al. (2020) have made comments on the precautionary measures to minimize the risk of transmission of the virus in Singapore. COVID 19 spread in a faster manner, the weak health system is not a vehicle of transmission of health workers with the worst preventive and control practices. Jackson et al. (2020) made an assessment of this fact in Tanzania.
Need for a mathematical model and motivation
For better prevention and preparation, the lifetime of the virus can be calculated using mathematical models. These models can include reported information about the population in an area. The actual preparation for a pandemic depends on the actual cases in the population, regardless of whether they have been identified or not, said Srinivasa Rao of Augusta University. In the USA, with better numbers, we can better estimate how long the virus will last and how much it will deteriorate. How can health systems and health workers prepare for what is needed without these numbers? Rao said. Better numbers are also important to better protect people and general pandemic preparedness (Coronavirus Death Toll and Trends Worldometer 2020). This motivates us to do this work to predict and estimate how long the virus will last.
Literature survey on mathematical models
Artificial intelligence techniques like fuzzy logic (FL), neural networks (NN), and evolutionary computing (EC) can be applied to discuss COVID-19 data and predict the useful results to save the life of the global population. In this subsection, a literature survey on mathematical models related to artificial intelligence techniques like FL, NN, EC, deep learning (DL), and other related fields are made.
In Park et al. (2020), a review on the disease COVID-19 prediction and drug development using artificial intelligence (AI). In Jamshidi et al. (2020), AI and DL methods GANAs (Generative Adversarial Networks), ELM ( Extreme Learning Machine) , and LSTM (Long /Short Term Memory) are used to predict the results in COVID-19. In Hao et al. (2020), to predict the growth range of confirmed new cases, new deaths, and new cured cases in China and the USA, ENN (Elman neural network), LSTM, and SVM (support vector machine) are used. An SVM with fuzzy granulation is also used. Ahmad and Asad (2020) predicted the counts of confirmed, recovered, and death cases from the period July 11 to July 17, 2020, using an ANN (artificial neural network) with the help of the data set from February 25 to July 10, 2020, in Pakistan. In Dhamodharavadhan et al. (2020), the future of India is predicted using SNN (Statistical Neural Network) models and their version. In El-Shafeiy et al. (2021), to predict the severity of COVID-19 in patients, quantum neural network (CQNN) is used. In Gupta et al. (2020), to predict the epidemic pattern, an GRNN (generalized regression neural network) model optimized with FPA (flower pollination algorithm ) is designed. In Ghazaly et al. (2020), to predict the outbreak COVID-19 use AI and DL with time series using nonlinear regressive network (NAR). Niazkar and Niazkar (2020) predicted the COVID-19 outbreak by prediction models based on ANN. In Tamang et al. (2020), to predict and forecast the number of death due to COVID-19, ANN-based curve fitting is used. In Uddin et al. (2020), an intelligent monitoring system to monitor the people using deep CNN (Convolutional Neural Networks) models is used to prevent the spread of COVID-19.
In Asraf et al. (2020), to control the spread of COVID-19, how deep learning plays a major role is reviewed. Fokas et al. (2020), using the mathematical expression and deep learning network, predicted the number of infected cases in six nations the USA, Germany, Italy, Spain, France, and Sweden from the time of evolution of the epidemic. In Prasse et al. (2020), a network-based model, Network-Inference-Based Prediction Algorithm (NIPA), is used to predict the future evolution of the epidemic in all cities of Hubei Province, China. The network is composed of the cities and interactions of Hubei Province. An accurate prediction of the outbreak is noticed. In Pham et al. (2020), AI and big data are used to improve the COVID-19 situation.
In Pal et al. (2020), a Bayesian optimization framework to predict the risk category of a country is discussed. It is a shallow LSTM-based neural network. In Mishra et al. (2020), to forecast the future pattern of COVID infection used fuzzy time series (FTS) and ANN and compared with the ARIMA model with the help of the data set from March 17 to July 1, 2020. In Mollalo et al. (2020), the cumulative incidence rates of COVID-19 are predicted across the nation using MLP (multilayer perceptron) neural network. In Kasilingam et al. (2020), using an exponential model and machine learning, the early signs of COVID-19 up to March 26, 2020, are identified. In Perone (2020), an ARMA model is applied to monitor the diffusion of the outbreak in Italy, Russia, and the USA.
In Nesteruk (2020b), to predict the medical and economic all due to pandemic, the epidemic characteristics are estimated using SIR (susceptible infected removed) model. In Verachi et al. (2020), the SIR model is used to evaluate the cost of management strategy. In Vrugt et al. (2020), an SIR mathematical model with a dynamical density function is used for the spread of disease. In Zhang et al. (2020), a stochastic SIR mathematical model for a COVID-19 is developed to find the spread of the disease controlling value.
In Kikkisetti et al. (2020), to classify the lungs infected images the chest X-ray (CXR) and deep-learning CNN are applied. In Rasheed et al. (2020), CNN models and the logistic regression (LR) are used to classify CXR images. In Rahimzadeh and Attar (2020), for an unbalanced data set a neural network is used to detect COVID-19 cases. In Qiao et al. (2020), using deep neural networks CXR images of COVID-19 are classified from pneumonia and healthy patients. Pham (2020) predicted the COVID-19 infected cases from the computed tomography (CT) scan images using AI methods, the CNNs. Wang et al. (2020), from the CXR images using a deep CNN, detected COVID-19 patients.
In Irmak (2020), CNN architectures are used to detect the COVID-19 disease from two data sets of CXR images. In Lozano et al. (2020), information to predict a fatal outcome in patients with COVID-19 is provided using an ANN. In Makris et al. (2020), to detect infected patients from CXR images CNNs are used. In Sekeroglu and Ozsahin (2020), by the training of deep learning and machine learning classifiers detected COVID-19 patients from their CXR images. In Singh et al. (2020), a deep CNN is to identify the infection of COVID-19 from the CXR image of the lungs of the patients to save the medical doctors time in diagnosis.
In Biswas et al. (2020) to study the dynamics from March 1, 2020, in India used mathematical models to fit with the data set of infected cases and predicted the future infection in India. In Boulmezaoud (2020), a mathematical model for the dynamics of transmission is designed to study the evolution of the epidemic. In Khajji et al. (2020), a discrete mathematical model for the transmission dynamics of both human and animal in different regions is designed. In Pereira et al. (2020), a mathematical model to predict the infection dynamics of Brazil is studied. In Rǎdulescu et al. (2020), a traditional mathematical model for the dynamics of spread in the New York State is considered to predict the infection. In Kyrychko et al. (2020), a mathematical model for the dynamics of the transmission of the disease in Ukraine is analyzed. In Zeb et al. (2020), a mathematical model is designed by using isolation class first to predict the dynamical behavior of the disease infection. In Zhang et al. (2020), a stochastic model for dynamics of the unique disease transmission in Mainland China is designed and it is found that the outbreak would be early March 2020 in and around Mainland China. In Zhu et al. (2020), to estimate the unknown data in China, an epidemic model is introduced. In Zuo et al. (2020), a mathematical model to provide total death in Asian nations is suggested.
In Cherniha and Davydovych (2020), a mathematical model is designed to predict the count of COVID-19 cases in China, Austria, Poland, and France. In Chen et al. (2020), a mathematical model is used to calculate the disease transmission in a population by infected one. In Gopalan and Misra (2020), a review on COVID-19 from various databases is given. In Zhou et al. (2020), a review on AI models for COVID-19 drug is made. In Hethcote (Dec. 2000), mathematical models for infectious diseases spread in the population are reviewed and are applied to some diseases. In Miao et al. (2020), a model to find the transmission of COVID-19 and infection risk is designed during this lockdown. And, after lockdown, at the time of the entry of business to find the net profit applied this model.
In Bertozzi et al. (2020), three models are analyzed to forecast and access the cause of the epidemic region-wise. And, in the absence of a vaccine, the impact of imposing and the danger of relaxation of social distancing is addressed. In Appadu et al. (2021), an iterative method based on Euler’s method and cubic spline interpolation is studied to forecast values from June 01, 2020, using the data from February 15, 2020, to May 31, 2020. In Nesteruk (2020a), to predict the infected cases on February 10, 2020, in Mainland China, a mathematical model is used. In Perc et al. (2020), an iterative method is used to forecast the daily growth rate by giving the input values the number of confined cases. In Sameni (https://arxiv.org/abs/2003.11371), mathematical models that predict the patterns of the propagation of the epidemic disease COIVID-19 are given for a better understanding of the spread.
In Zhu and Pham (2018), a review on AI models for COVID-19 drug is made. In Zakary et al. (2020), using a mathematical model the infection in Morocco is estimated and predicted. In Serhani and Labbardi (2020), a modified compartmental model for the spread of the disease in Morocco is introduced and it is observed that the strict home containment plays a major role in spread control. In Pongkitivanichkul and D. Samart1, T. Tangphati, P. Koomhin, P. Pimton, 6, P. Dam-O, A. Payaka, and P. Channuie, (2020), a renormalization group-inspired logistic function is used to analyze the data of infected cases of the nations in the first phase by taking n=1. Rosti et al. (2020), taking the airflow due to cough, predict the reach of infectious droplets to a destination emitted from mouth during a cough. In Scherf et al. (2020), the steps are taken in Brazil to manage the pandemic situation and a review is given. In Cherry and Krogstad (2001), a review on the pandemic is given for future preparedness. In Wynants et al. (2020), a review on the prediction models for diagnosing COVID-19 in patients is given.
It is predicted that 40 % to 70 % of the global population will be infected in the coming years in Nash .C. Mediaite (https://www.mediaite.com/news/harward-professor-sounds--alarm on likely coronavirus pandemic-.40to-70ofworldcouldbe-infectedthisyear). In Petropoulos, a continuation of coronavirus COVID-19 is predicted using a sample. In Muttrack and Scherhov (2020), the impact of a period of life expectancy is discussed. Forecasting Team Nature (2020) using the SEIR method predicted COVID-19 patterns and traced the possible outcomes for the period September 22, 2020, to February 28, 2021, using the COVID-19 cases and mortality data from February 1, 2020, to September 21, 2020. Time series are used to analyze each state of the USA. SEIR stands for the Susceptible Exposed Infectious Recovered computational method. In Joshua and Ronald (2020, 2020), COVID-19 mortality is estimated within 1 million deaths and observed it reduced the remaining life of the people of the USA by less than one part in one thousand. COVID-19 claimed life within months but not over decades like other epidemics such as HIVAIDS and opioids.
In Jewell et al. (2020), the importance of mathematical models to make decisions on public health issues and to reduce mortality by using the available resources during this COVID-19 pandemic situation is discussed. But, no mathematical expression is given in Jewell et al. (2020). In Gupta et al. (2020), using a relation between COVID-19 spread and weather parameters predicted Indian states with high risk using the USA prediction model. Singh et al. (2020) predicted the coronavirus COVID-19 disease spread graphs concerning the counts of confirmed cases, deaths, and recoveries during the period April 24 to July 7, 2020, using ARIMA model for the worst affected 15 countries ranking top in the world.
In Banerjee et al. (2020), excess counts of deaths over one year in different levels of transmission of COVID-19 are determined. In Ghisolfi et al. (2020), the fatality rate for Eastern Europe nations are estimated. In the USA, CDCP—Centers for Disease Control and Prevention, instructs the people to stay at home when they are sick, avoid touching nose and mouth by covering them, and frequently wash hands using soap before and after touching any object, to avoid the spread of coronavirus (Centers for Disease Control and Prevention 2020).
The research work, the lifetime prediction presented in this article is entirely new and differs from all other articles in the literature.
Motivation of this work
To speed up the steps taken to save the life of people the mathematical models will be helpful to make decisions on public health issues and to reduce mortality by using the available resources during this COVID-19 pandemic period. Knowing how long this infection will be in the USA, public health decisions can be made by the government and voluntary organizations and mortality can be reduced. The works of Jewell et al. (2020) motivated me to do this work to find the lifetime of coronavirus COVID-19 to save the life of the people. The daily news about the deaths globally and the data about 215 nations and the mathematical model to predict the maximum number of death in the USA due to COVID-19 in the coming days of Phon (Pham 2020) motivate to predict the lifetime of coronavirus COVID-19 (the time of no death due to COVID-19) in the USA using death counts of the USA from February 29 to April 22, 2020, if everyone follows the guidelines of WHO and the advice of healthcare workers.
Main results of this article
This article first reviews the origin of the coronavirus, the types of the coronavirus, and the transmission of the bat virus to humans. Our main aim is to better protect people and general pandemic preparedness by predicting the lifetime of the disease-causing virus using mathematical models with five and six unknown parameters for the uncertainty of death. In this article, the main results are the prediction of the lifetime of coronavirus COVID-19 ( the time of no death due to COVID-19) in the USA using three mathematical models. Based on the total number of death at time t, the first, second, and third models predict the lifetime of coronavirus COVID-19 as 240.79 days, 240.35 days, and 272.37 days, respectively, from February 29, 2020. On taking the maximum value, it is predicted from three models, the lifetime of coronavirus COVID-19 is 272.37 days from February 29, 2020. That is, after 272.37 days from February 29, 2020 (that is, after December 2020 ), there will be no death and, on comparing with the death counts from the live updates of WHO, there will be death in the USA due to COVID-19 even after December 2020.
And, based on the death rate, the first, second, and third models predict the lifetime of coronavirus COVID-19 as 1285.12 days, 1281.33 days, and 1464.76 days, respectively, from February 29, 2020. On taking the maximum value, it is predicted from three models, the lifetime of coronavirus COVID-19 is 1464.76 days from February 29, 2020. That is, after 1464.76 days from February 29, 2020 (that is, after March 2024 ), there will be no death due to coronavirus COVID-19 if everyone follows the guidelines of WHO and advice of healthcare workers.
Finally, in this article, it is predicted from three models, the lifetime of coronavirus COVID-19 in the USA as 1464.76 days from February 29, 2020. That is, it is predicted by calculation from three models, after December 2024 we can expect no death in the USA due to COVID-19, provided if everyone follows the guidelines of WHO and the advice of healthcare workers
Construction of this article
In Sect. 1, we have introduced the virus with a crown followed by the review which killed humans. In Sect. 2, the transmission of coronavirus from bat to human is followed by a review. And the expected future transmission is also presented. In Sect. 3, a mathematical model for COVID-19 is discussed which predicts the maximum number of death in the USA due to COVID-19 in the coming days. In Sect. 4, the lifetime of coronavirus COVID-19 in the USA is calculated using a mathematical model, Model-I. In Sect. 5, the lifetime of coronavirus COVID-19 in the USA is calculated using a mathematical model, Model-II. In Sect. 6, the lifetime of coronavirus COVID-19 in the USA is calculated using a mathematical model, Model-III. Finally, in Sect. 7, this article suggests several steps to control the coronavirus spread and severity of the disease and plan of research in coronavirus COVID-19.